Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Human Metabolome Technologies,Inc. Buys Back 37,300 Shares for ¥27 million
Source disclosure: March 03, 2026, 15:30 JST
Published by Pulse News Wire: March 03, 2026, 15:31 JST
Human Metabolome Technologies,Inc. [6090.T]
TOKYO, Mar 03 (Pulse News Wire) – Human Metabolome Technologies,Inc. (6090.T) announced progress on its share repurchase program.
The company acquired 37,300 shares for a total of ¥27 million during the period from February 13, 2026 to December 31, 2026 through open market purchases. The program is 14.9% complete with 37,300 shares acquir
Source disclosure: March 03, 2026, 15:30 JST Published by Pulse News Wire: March 03, 2026, 15:31 JST
TOKYO, Mar 03 (Pulse News Wire) – Human Metabolome Technologies,Inc. (6090.T) announced progress on its share repurchase program.
The company acquired 37,300 shares for a total of ¥27 million during the period from February 13, 2026 to December 31, 2026 through open market purchases. The program is 14.9% complete with 37,300 shares acquired to date.
